ArticleAME case reports2025
Management of stage IVa thymoma with coexistence of Lambert-Eaton myasthenic syndrome and myasthenia gravis in a postpartum female case report.
Article in AME case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Thymoma is a rare malignancy accounting for less than 2% of annual cancer diagnoses. While commonly associated with myasthenia gravis (MG), its association with Lambert-Eaton myasthenic syndrome (LEMS), a paraneoplastic syndrome typically linked to small cell lung cancer, is rare. Even rarer are cases with overlapping features of both syndromes. Case Description: We report a 36-year-old postpartum Asian woman with overlapping clinical features of LEMS and MG attributed to her stage IVa thymoma, and minimally responsive to chemotherapy, thus requiring aggressive surgical debulking with cardiopulmonary bypass (CPB). She presented 2.5 weeks postpartum with dyspnea and right pleuritic chest pain. Computed tomography (CT) imaging demonstrated a >20 cm heterogeneous right pleural mass, and a separate 10 cm anterior mediastinal mass invading the superior vena cava (SVC) and innominate vein. Biopsy confirmed thymoma type B2. Further positron emission tomography (PET)/CT imaging showed no distant metastasis. The Multidisciplinary Tumor Board recommended neoadjuvant chemotherapy due to vascular invasion, followed by surgical resection. A month later, she developed worsening dyspnea, diplopia, dysphagia, and generalized extremity weakness with serologic testing positive for acetylcholine receptor (AChR) blocking antibodies. She was diagnosed with a paraneoplastic neuromuscular syndrome attributed to her stage IVa malignant thymoma. She was started on pyridostigmine, an acetylcholinesterase inhibitor, improving her symptoms. Restaging CT showed minimal response to chemotherapy, necessitating palliative debulking surgery, including right extrapleural pneumonectomy, thymectomy, SVC repair, and pericardial and diaphragm reconstruction. Pathology confirmed diffuse thymoma type B2 with R1 resection. She recovered uneventfully and underwent adjuvant radiation therapy, and remains disease-free on interval surveillance imaging. Conclusions: This rare case of stage IVa thymoma in a postpartum Asian woman with overlapping features of LEMS and MG highlights the role of acetylcholinesterase inhibitors for symptom management, and the role of aggressive radical debulking surgery with CPB, in a young, otherwise healthy patient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.